Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma
Yung Lyou, Jonathan E. Rosenberg, Jean Hoffman‐Censits, David I. Quinn, Daniel P. Petrylak, Matthew D. Galsky, Ulka N. Vaishampayan, Ugo De Giorgi, Sumati Gupta, Howard A. Burris, Jessica Rearden, Li Ai, Cindy Xu, Corina Andresen, Susan Moran, Siamak Daneshmand, Dean F. Bajorin, Sumanta K. Pal, Petros Grivas
Topics & Concepts
MedicineMetastatic Urothelial CarcinomaUrothelial carcinomaSalvage therapyOncologyTargeted therapyCarcinomaUrothelial cancerInternal medicineCancer researchCancerChemotherapyBladder cancerBladder and Urothelial Cancer TreatmentsFibroblast Growth Factor ResearchUrinary and Genital Oncology Studies